ADC Therapeutics SA: directors' dealings · United States · SEC (Form 4) Explore the full insider trade history of ADC Therapeutics SA, a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €139.9m. The latest transaction was reported on 3 June 2026 (Attribution). Among the most active insiders: BIZZARI JEAN-PIERRE. All data is accessible without an account.
€260,054
9 ops.
Sell Volume
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 3 June 2026
All Executives56 Thresholds0 Prospectus0 Other0
Declarations 56 total
◆ Director · Executives · 1 Jun 2026
45,000 shares 0Common Shares SEC:0001628280-26-040487:0
● Director · Executives · 3 Jun 2026
12,600 shares @ US$3.08 100.0% of flow Common Shares SEC:0001628280-26-040487:1
◆ Director · Executives · 1 Jun 2026
45,000 shares 0Common Shares SEC:0001628280-26-040488:0
● Director · Executives · 3 Jun 2026
12,600 shares @ US$3.08 36.7% of flow Common Shares SEC:0001628280-26-040488:1
◆ Director · Executives · 1 Jun 2026
45,000 shares 0Common Shares SEC:0001628280-26-040489:0
● Director · Executives · 3 Jun 2026
2,156 shares @ US$3.08 36.8% of flow Common Shares SEC:0001628280-26-040489:1
◆ Director · Executives · 1 Jun 2026
45,000 shares 0Common Shares SEC:0001628280-26-040490:0
● Director · Executives · 3 Jun 2026
2,596 shares @ US$3.08 36.8% of flow Common Shares SEC:0001628280-26-040490:1
◆ Director · Executives · 1 Jun 2026
45,000 shares 0Common Shares SEC:0001628280-26-040491:0
● Director · Executives · 3 Jun 2026
12,600 shares @ US$3.08 36.7% of flow Common Shares SEC:0001628280-26-040491:1
◆ Director · Executives · 1 Jun 2026
45,000 shares 0Common Shares SEC:0001628280-26-040492:0
● Director · Executives · 3 Jun 2026
15,196 shares @ US$3.08 38.0% of flow Common Shares SEC:0001628280-26-040492:1
◆ Director · Executives · 1 Jun 2026
45,000 shares 0Common Shares SEC:0001628280-26-040493:0
● Director · Executives · 3 Jun 2026
12,600 shares @ US$3.08 36.7% of flow Common Shares SEC:0001628280-26-040493:1
● Chief Financial Officer · Executives · 6 Dec 2025
53,236 shares @ US$3.29 22.6% of flow Common Shares SEC:0001628280-25-056168:0
● Chief Legal Officer · Executives · 6 Dec 2025
49,508 shares @ US$3.29 23.2% of flow Common Shares SEC:0001628280-25-056169:0
● Chief Accounting Officer · Executives · 6 Dec 2025
7,140 shares @ US$3.29 19.3% of flow Common Shares SEC:0001628280-25-056170:0
● Chief Medical Officer · Executives · 6 Dec 2025
41,068 shares @ US$3.29 19.9% of flow Common Shares SEC:0001628280-25-056171:0
● Chief Executive Officer · Executives · 6 Dec 2025
233,146 shares @ US$3.29 26.1% of flow Common Shares SEC:0001628280-25-056172:0
● Director · Executives · 13 Jun 2025
12,600 shares @ US$3.58 42.7% of flow Common Shares SEC:0001628280-25-031890:0
● Director · Executives · 13 Jun 2025
12,600 shares @ US$3.58 42.7% of flow Common Shares SEC:0001628280-25-031891:0
● Director · Executives · 13 Jun 2025
2,144 shares @ US$3.58 42.6% of flow Common Shares SEC:0001628280-25-031892:0
● Director · Executives · 13 Jun 2025
2,584 shares @ US$3.58 42.6% of flow Common Shares SEC:0001628280-25-031893:0
● Director · Executives · 13 Jun 2025
12,600 shares @ US$3.58 42.7% of flow Common Shares SEC:0001628280-25-031894:0
● Director · Executives · 13 Jun 2025
15,184 shares @ US$3.58 44.2% of flow Common Shares SEC:0001628280-25-031895:0
25 of 56 declarations
Load more (31 remaining)